CD8A and cancer: In ordinal logistic models adjusted for age, sex, study batch, and cancer site, MSI-high status was associated with greater odds of higher density quantile for CD3+CD4+ naive and regulatory subsets, all CD3+CD8+ subsets, double negative T cells, and CD3- non-tumor cells in epithelial tissue areas (Table 2).